Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded intraocular lens (IOL) delivery system with Clareon® IOL

Novartis International AG / Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded intraocular lens (IOL) delivery system with Clareon® IOL . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

• AutonoMe(TM) preloaded IOL delivery system provides easy, intuitive control for precise IOL insertion during cataract surgery
   

New Clareon^® IOL in vitro data and early clinical experience to be presented at European Society of Cataract & Refractive Surgeons congress

Basel, October 6, 2017 - Alcon, the global leader in eye care and a division of Novartis, has achieved European CE Mark for the Clareon^® IOL with the AutonoMe(TM) delivery system.  AutonoMe(TM) is the first-and-only automated, disposable, pre-loaded IOL delivery system that enables precise delivery of the IOL into the capsular bag in patients undergoing cataract surgery[1-2]. The new device is being introduced with the Clareon^® IOL, a new BioMaterial with an advanced design that enables sharp, crisp vision; low edge glare; and, unsurpassed optic clarity[2]*. These new innovations, along with supporting scientific data, will be presented at the XXXV congress of the European Society of Cataract & Refractive Surgeons (ESCRS) taking place October 7 - 11 in Lisbon, Portugal.

"With the introduction of Clareon^® AutonoMe(TM), we are proud to unveil our latest innovations to benefit doctors and their patients undergoing cataract surgery," said Mike Ball, Chief Executive Officer, Alcon. "Throughout Alcon's history, we have worked with doctors to enhance and transform the way cataract surgery is performed. Clareon^® AutonoMe(TM) builds upon the comprehensive legacy of AcrySof^® by offering cataract surgeons easy, intuitive control of IOL delivery with the newest optic material."

The AutonoMe(TM) delivery system, preloaded with the Clareon^® IOL, is designed with advancements intended to benefit both surgeons and cataract patients. Its automated CO₂-powered delivery mechanism and intuitive, ergonomic design allow precise and simplified single-handed control of IOL placement during cataract surgery[1-2].

"Comfort and efficiency during the cataract surgery are key to achieving better outcomes. This new device is expected to improve the procedure and ultimately to reduce surgical time," said Prof. Rudolph Nuijts, University of Maastricht, Netherlands. "This is great news for surgeons because Clareon^® AutonoMe(TM) provides a cutting-edge, intuitive and easy-to-use device that allows precise and controlled IOL delivery."